UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing

Scientific reports, 2020-01, Vol.10 (1), p.1634-1634, Article 1634

2020

Volltextzugriff (PDF)

A Reliable Phenotype Predictor for Human Immunodeficiency Virus Type 1 Subtype C Based on Envelope V3 Sequences

Journal of Virology, 2006-05, Vol.80 (10), p.4698-4704

2006

Volltextzugriff (PDF)

Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use

PloS one, 2011-07, Vol.6 (7), p.e22020-e22020

2011

Volltextzugriff (PDF)

Measurement error and variant-calling in deep Illumina sequencing of HIV

Bioinformatics (Oxford, England), 2019-06, Vol.35 (12), p.2029-2035

2019

Volltextzugriff (PDF)

The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C

Journal of Virology, 2003-04, Vol.77 (7), p.4449-4456

2003

Volltextzugriff (PDF)

CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity

Journal of Virology, 2012-09, Vol.86 (18), p.10218-10220

2012

Volltextzugriff (PDF)

Evolution of CCR5 Use before and during Coreceptor Switching

Journal of Virology, 2008-12, Vol.82 (23), p.11758-11766

2008

Volltextzugriff (PDF)

“Resistance” to PSC-RANTES Revisited: Two Mutations in Human Immunodeficiency Virus Type 1 HIV-1SF162 or Simian-Human Immunodeficiency Virus SHIVSF162-p3 Do Not Confer Resistance

Journal of Virology, 2010-06, Vol.84 (11), p.5842-5845

2010

Volltextzugriff (PDF)

Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region

Genetics (Austin), 2010-05, Vol.185 (1), p.293-303

2010

Volltextzugriff (PDF)

HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya

AIDS (London), 2018-11, Vol.32 (17), p.2485-2496

2018

Volltextzugriff (PDF)

Validity of Self-Reported Hepatitis C Virus Status Among Criminal Justice-Involved Persons Living With HIV

Journal of correctional health care, 2021-09, Vol.27 (3), p.167

2021

Volltextzugriff (PDF)

Gp41 and Gag amino acids linked to HIV‐1 protease inhibitor‐based second‐line failure in HIV‐1 subtype A from Western Kenya

Journal of the International AIDS Society, 2017-11, Vol.20 (3), p.n/a

2017

Volltextzugriff (PDF)

One-Step Ligation on RNA Amplification for the Detection of Point Mutations

The Journal of molecular diagnostics : JMD, 2015-11, Vol.17 (6), p.679-688

2015

Volltextzugriff (PDF)

Improved HIV-1 Viral Load Monitoring Capacity Using Pooled Testing With Marker-Assisted Deconvolution

Journal of acquired immune deficiency syndromes (1999), 2017-08, Vol.75 (5), p.580

2017

Volltextzugriff (PDF)

Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C

Journal of acquired immune deficiency syndromes (1999), 2011-01, Vol.56 (1), p.9

2011

Volltextzugriff (PDF)

HIV Second-Line Failure and Drug Resistance at High- and Low-Level Viremia in Western Kenya

AIDS (London), 2018-11, Vol.32 (17), p.2485-2496

2018

Volltextzugriff (PDF)

Treatment failure and drug resistance in HIV‐positive patients on tenofovir‐based first‐line antiretroviral therapy in western Kenya

Journal of the International AIDS Society, 2016-01, Vol.19 (1), p.20798-n/a

2016

Volltextzugriff (PDF)

2237. Validity of Self-Reported HCV Status Among Justice-Involved Persons Living with HIV

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S662-S662

2018

Volltextzugriff (PDF)

Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-line antiretroviral therapy by WHO 2010 guidelines

AIDS research and human retroviruses, 2013-07, Vol.29 (7), p.985

2013

Volltextzugriff (PDF)

Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates

Virology (New York, N.Y.), 2006-12, Vol.356 (1), p.95-105

2006

Volltextzugriff (PDF)

2504. Laboratory Evaluation of HIV-1 Viral Load Pooling with Marker-Assisted Deconvolution

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S868-S868

2019

Volltextzugriff (PDF)

885. HIV-1 Treatment Failure and Extensive Drug Resistance in Perinatally Infected Children Failing First-Line Antiretroviral Therapy in Western Kenya

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S20-S20

2019

Volltextzugriff (PDF)

QUOTATION_MARKResistanceQUOTATION_MARK to PSC-RANTES Revisited: Two Mutations in Human Immunodeficiency Virus Type 1 HIV-1SF162 or Simian-Human Immunodeficiency Virus SHIVSF162-p3 Do Not Confer Resistance

Journal of virology, 2010-06, Vol.84 (11), p.5842-5845

2010

Volltextzugriff (PDF)

"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance

Journal of virology, 2010-06, Vol.84 (11), p.5842-5845

2010

Volltextzugriff (PDF)

Use of alternate coreceptors on primary cells by two HIV-1 isolates

Virology (New York, N.Y.), 2005-08, Vol.339 (1), p.136-144

2005

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(22)
Science & Technology
(20)
Life Sciences & Biomedicine
(18)
Hiv-1 - Genetics
(15)
Virology
(13)
Hiv Infections - Virology
(11)
Immunology
(9)
Infectious Diseases
(9)
Molecular Sequence Data
(9)
Aids/hiv
(8)
Female
(8)
Hiv
(8)
Mutation
(8)
Amino Acid Sequence
(7)
Biological And Medical Sciences
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
Hiv-1 - Drug Effects
(7)
Human Immunodeficiency Virus
(7)
Human Immunodeficiency Virus 1
(7)
Microbiology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing

A Reliable Phenotype Predictor for Human Immunodeficiency Virus Type 1 Subtype C Based on Envelope V3 Sequences

Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use

Measurement error and variant-calling in deep Illumina sequencing of HIV

The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C

CCR5 Mutations Distinguish N-Terminal Modifications of RANTES (CCL5) with Agonist versus Antagonist Activity

Evolution of CCR5 Use before and during Coreceptor Switching

“Resistance” to PSC-RANTES Revisited: Two Mutations in Human Immunodeficiency Virus Type 1 HIV-1SF162 or Simian-Human Immunodeficiency Virus SHIVSF162-p3 Do Not Confer Resistance

Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein region

HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya

Validity of Self-Reported Hepatitis C Virus Status Among Criminal Justice-Involved Persons Living With HIV

Gp41 and Gag amino acids linked to HIV‐1 protease inhibitor‐based second‐line failure in HIV‐1 subtype A from Western Kenya

One-Step Ligation on RNA Amplification for the Detection of Point Mutations

Improved HIV-1 Viral Load Monitoring Capacity Using Pooled Testing With Marker-Assisted Deconvolution

Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C

HIV Second-Line Failure and Drug Resistance at High- and Low-Level Viremia in Western Kenya

Treatment failure and drug resistance in HIV‐positive patients on tenofovir‐based first‐line antiretroviral therapy in western Kenya

2237. Validity of Self-Reported HCV Status Among Justice-Involved Persons Living with HIV

Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-line antiretroviral therapy by WHO 2010 guidelines

Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates

2504. Laboratory Evaluation of HIV-1 Viral Load Pooling with Marker-Assisted Deconvolution

885. HIV-1 Treatment Failure and Extensive Drug Resistance in Perinatally Infected Children Failing First-Line Antiretroviral Therapy in Western Kenya

QUOTATION_MARKResistanceQUOTATION_MARK to PSC-RANTES Revisited: Two Mutations in Human Immunodeficiency Virus Type 1 HIV-1SF162 or Simian-Human Immunodeficiency Virus SHIVSF162-p3 Do Not Confer Resistance

"Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance

Use of alternate coreceptors on primary cells by two HIV-1 isolates

Suchergebnisse filtern